Vavricka John bought AVIR
January 31, 2026 · Form 4 insider transaction
Vavricka John bought 119,520 shares of Atea Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
119,520
Price
$0.00
Total value
N/A
InsiderVavricka John
RoleOfficer
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJanuary 31, 2026
Filing dateFebruary 3, 2026
Shares owned after119,520
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The option vests and becomes exercisable in forty-eight (48) equal monthly installments following January 31, 2026 such that the option is fully vested on January 31, 2030.